For reasons explained below (refer to section), PD-L1 expression correlates to the response to anti-PD-1 therapy in cHL and some non-GCB DLBCL subtypes, but has no predictive value for other subtypes [128,129]. This evidence concerns the gene PDCD1 and classic Hodgkin lymphoma.